Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity_老虎社区_美港股上老虎

Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity

T-Reuters2021-05-05

Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

Elleysss
·2021-05-05
great!
回复
点赞
举报
VictorTan
·2021-05-05
Omg
回复
1
举报
Bubu0106
·2021-05-05
Ohh
回复
2
举报
7e17884c
·2021-05-05
Good
回复
1
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2133542329?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-05-05 15:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2133542329","market":"us","top_or_hot":-1,"title":"Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity","media":"T-Reuters","content":"<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity\n</h2>\n\n<h4 class=\"meta\">\n\n2021-05-05 15:15 北京时间&nbsp;&nbsp;&nbsp;<strong>T-Reuters</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In ...</p>\n\n<a href=\"None\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":null,"article_id":"2133542329","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2133542329","pubTimestamp":1620198959,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"T-Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Un","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"诺和诺德首席执行官说，我们可以看到肥胖症的增长又回来了","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.","kind":"highlight","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":102668585,"gmtCreate":1620207764947,"gmtModify":1631890355178,"author":{"id":"3582775015485523","authorId":"3582775015485523","name":"Elleysss","avatar":"https://static.tigerbbs.com/fc575791aab67b344dbb075f41c1af57","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582775015485523","authorIdStr":"3582775015485523"},"htmlText":"great!","listText":"great!","text":"great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102668585","repostId":2133542329,"repostType":4,"repost":{"id":"2133542329","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1620198959,"share":"https://www.laohu8.com/m/news/2133542329?lang=&edition=full","pubTime":"2021-05-05 15:15","market":"us","language":"en","title":"Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2133542329","media":"T-Reuters","summary":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Un","content":"<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-05-05 15:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2133542329","content_text":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102634085,"gmtCreate":1620204328747,"gmtModify":1634207005675,"author":{"id":"3581643954540827","authorId":"3581643954540827","name":"VictorTan","avatar":"https://static.tigerbbs.com/e8f6af35b29d90a5cf41d25d71ee2335","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581643954540827","authorIdStr":"3581643954540827"},"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102634085","repostId":2133542329,"repostType":4,"repost":{"id":"2133542329","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1620198959,"share":"https://www.laohu8.com/m/news/2133542329?lang=&edition=full","pubTime":"2021-05-05 15:15","market":"us","language":"en","title":"Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2133542329","media":"T-Reuters","summary":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Un","content":"<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-05-05 15:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2133542329","content_text":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102844240,"gmtCreate":1620200112280,"gmtModify":1634207031349,"author":{"id":"3575191923496169","authorId":"3575191923496169","name":"Bubu0106","avatar":"https://static.tigerbbs.com/d77c5b4980b3cb19d22f467d36ed248b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3575191923496169","authorIdStr":"3575191923496169"},"htmlText":"Ohh","listText":"Ohh","text":"Ohh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102844240","repostId":2133542329,"repostType":4,"repost":{"id":"2133542329","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1620198959,"share":"https://www.laohu8.com/m/news/2133542329?lang=&edition=full","pubTime":"2021-05-05 15:15","market":"us","language":"en","title":"Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2133542329","media":"T-Reuters","summary":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Un","content":"<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-05-05 15:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2133542329","content_text":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102841305,"gmtCreate":1620199143107,"gmtModify":1634207035200,"author":{"id":"3562323522882055","authorId":"3562323522882055","name":"7e17884c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3562323522882055","authorIdStr":"3562323522882055"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102841305","repostId":2133542329,"repostType":4,"repost":{"id":"2133542329","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1620198959,"share":"https://www.laohu8.com/m/news/2133542329?lang=&edition=full","pubTime":"2021-05-05 15:15","market":"us","language":"en","title":"Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2133542329","media":"T-Reuters","summary":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Un","content":"<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-05-05 15:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2133542329","content_text":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":12,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}